ContractClinical Study Agreement • January 11th, 2024
Contract Type FiledJanuary 11th, 2024Clinical Study Agreement This Clinical Study Agreement (“Agreement”) is effective as of the date of the last signature (“Effective Date”) between IQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8 - Karlín, , Czech Republic, Identification number: 247 68 651, Tax identification number: CZ247 68 651, XXX (“IQVIA”); Alexion Pharmaceuticals, Inc., having a place of business at 121 Seaport Blvd, Boston, MA 02210 USA Tax identification number: 85-4136092 ], XXX (“Alexion”), XXX XXX, přednosta Interní hematologické a onkologické kliniky Fakultní nemocnice Brno (“Investigator“),and Fakultni nemocnice Brno having a place of business at Jihlavska 20, 625 00 Brno, Czech Republic, represented by MUDr. Ivo Rovný, MBA, Director, Identification number: 65269705, Tax identification number: CZ65269705 (“Institution”). Background Alexion desires Institution and Investigator (jointly, “Site”) to conduct the clinical study “A Long-term Extension (LTE) S
ContractClinical Study Agreement • July 1st, 2022
Contract Type FiledJuly 1st, 2022Clinical Study Agreement This Clinical Study Agreement (“Agreement”) between: IQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8 - Karlín, Czech Republic, Identification number: 247 68 651, Tax identification number: CZ247 68 651, represented by Ing. Eva Falbrová, Managing Director (“IQVIA”) and Alexion Pharmaceuticals, Inc., having a place of business at 121 Seaport Blvd, Boston, MA 02210 USA, Tax identification number: 85-4136092, represented by Doug Schantz, Vice President Clinical Operations(“Alexion”) and , Czech Republic(“Investigator”) and Fakultní nemocnice Brno, having a place of business at Jihlavská 20, 625 00 Brno, Czech Republic, represented by MUDr. Ivo Rovný, MBA, Director, Identification number: 65269705, Tax identification number: CZ65269705 (“Institution”), will become effective on the date of its publication in the Register of Agreements (the „Effective Date “). Smlouva o klinické studii Tato Smlouva o klinické studii (dá